Moreover, several studies have been reported that PAR2 could modulate numerous cancer cell functions, such as proliferation, migration and apoptosis, by EGFR transactivation or itself (Darmoul et al., 2004; Michel et al., 2014; Arakaki et al., 2018; Pawar et al., 2019). The gene discussed is EGFR; the disease is cancer.